RepliCel Life Sciences Inc (OTCQB:REPCF)

0.277
Delayed Data
As of Apr 20
 -0.01 / -3.48%
Today’s Change
0.26
Today|||52-Week Range
0.77
-10.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-27.7K-4.7M-3.9M-3.2M
 
 
 
 
 
Depreciation5.9K6.9K5.5K4.4K
 
 
 
 
 
Total Other Cash Flow519.5K717.2K100.1K623.7K
 
 
 
 
 
Funds From Operations497.7K-4.0M-3.8M-2.6M
 
 
 
 
 
Funds From/For Other Operating Expenses17.7K42.7K-428.0K79.2K
 
 
 
 
 
Net Cash Flow - Operating Activities480.0K-4.0M-3.4M-2.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-1.4M---1.1M
 
 
 
Decrease In Investments0.000.001.2M0.00
 
 
Capital Expenditures-7.6K-9.2K-1.7K0.00
 
 
 
 
Net Cash Flow Investing-7.6K-1.4M1.2M-1.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.1M4.1M2.0M3.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing45.3K0.000.000.00
 
 
Net Cash Flow - Financing1.1M4.1M2.0M3.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.00------
 
Net Change In Cash1.5M-1.3M-280.9K-86.8K